Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2007

01-03-2007

Retroperitoneal and Truncal Sarcomas: Prognosis Depends Upon Type Not Location

Authors: Eduardo A. Perez, MD, Juan C. Gutierrez, MD, Frederick L. Moffat Jr, MD, Dido Franceschi, MD, Alan S. Livingstone, MD, Seth A. Spector, MD, Joe U. Levi, MD, Danny Sleeman, MD, Leonidas G. Koniaris, MD

Published in: Annals of Surgical Oncology | Issue 3/2007

Login to get access

Abstract

Background

Prognostication of truncal and retroperitoneal soft tissue sarcomas has traditionally been predicated on tumor location and grade.

Objective

To compare outcomes for patients with retroperitoneal or truncal sarcomas.

Methods

Retrospective analysis of a prospective cancer data registry from 1977 to 2004 was performed and outcomes were determined.

Results

The study group numbered 312 patients (median age 58 years, 54% male, 56% Caucasian, 14% black, 29% Hispanic). The most common tumor types were liposarcoma (35.9%), leiomyosarcoma (30.1%), and malignant fibrous histiocytoma (MFH) (19.5%). Tumor distributions were retroperitoneal (38.9%), pelvic (24.7%), abdominal (18.6%) and thoracic (17.9%). Median overall survival was 74 months. Operative resection was undertaken in 89.4% of cases and multiple surgeries (range 2–5) in 42.2%. Negative resection margins were obtained in 72.7% of patients. Univariate analysis comparing retroperitoneal versus truncal location demonstrated no significant differences in survival. Survival was improved in lower grade tumors (P < 0.02). Liposarcoma and fibrosarcoma were associated with improved survival (P < 0.0001). Multivariate analysis of pre-treatment variables showed increasing age, grade, histopathology (leiomyosarcoma and MFH) and metastasis to be associated with worse outcomes. Multivariate analysis of the treatment variables showed that surgery and negative resection margins were associated with improved survival (P < 0.001). No advantage for chemoradiotherapy could be demonstrated.

Conclusions

Successful operative resection can confer prolonged disease-free survival and cure for truncal and retroperitoneal sarcomas. Histological subtype, not location, is predictive of long-term survival. Future studies should focus on histological subtype rather than tumor location for truncal and retroperitoneal sarcomas.
Literature
1.
Lawrence W Jr, Donegan WL, Natarajan N, et al. Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg 1987; 205(4):349–59PubMedCrossRef
2.
Windham TC, Pisters PW. Retroperitoneal sarcomas. Cancer Control 2005; 12(1):36–43PubMed
3.
Massi D, Beltrami G, Capanna R, Franchi A. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance. Eur J Surg Oncol 2004; 30(10):1131–6PubMedCrossRef
4.
5.
Wunder JS, Healey JH, Davis AM, Brennan MF. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer 2000; 88(12):2721–30PubMedCrossRef
6.
7.
Clary BM, DeMatteo RP, Lewis JJ, et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol 2001; 8(4):290–9PubMedCrossRef
8.
Borden EC, Baker LH, Bell RS, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res 2003; 9(6):1941–56PubMed
9.
Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279(5350):577–80PubMedCrossRef
10.
Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002; 3(11):655–64PubMedCrossRef
11.
Perez EA, Livingstone AS, Franceschi D, et al. Current Incidence and Outcomes of Gastrointestinal Mesenchymal Tumors including GIST. J Am Coll Surg 2006 (in press)
12.
Torres U, Hawkins WG, Antonescu CR, DeMatteo RP. Hepatic follicular dendritic cell sarcoma without Epstein-Barr virus expression. Arch Pathol Lab Med 2005; 129(11):1480–3PubMed
13.
Khanna A, Walker G, Livingstone AS, et al. Does adjuvant 5-FU prolongs survival following pancreaticoduodenectomy? A meta-analysis. J Gastrointest Surg 2006 (in press)
14.
Oda Y, Tamiya S, Oshiro Y, et al. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Pathol Int 2002; 52(9):595–606PubMedCrossRef
15.
Miyajima K, Oda Y, Oshiro Y, et al. Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis. Histopathology 2002; 40(4):353–9PubMedCrossRef
16.
Antonescu CR, Viale A, Sarran L, et al. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin Cancer Res 2004; 10(10):3282–90PubMedCrossRef
17.
Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228(3):355–65PubMedCrossRef
18.
Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001; 92(2):359–68PubMedCrossRef
19.
Cormier JN, Huang X, Xing Y, et al. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 2004; 22(22):4567–74PubMedCrossRef
20.
Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995; 221(2):185–95PubMedCrossRef
21.
Koch BB, Karnell LH, Hoffman HT, et al. National cancer database report on chondrosarcoma of the head and neck. Head Neck 2000; 22(4):408–25PubMedCrossRef
22.
Sindwani R, Matthews TW, Thomas J, Venkatesan VM. Epithelioid leiomyosarcoma of the larynx. Head Neck 1998; 20(6):563–7PubMedCrossRef
23.
Linehan DC, Lewis JJ, Leung D, Brennan MF. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol 2000; 18(8):1637–43PubMed
24.
Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer 2004; 100(11):2448–55PubMedCrossRef
25.
Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003; 238(3):358–70; discussion 370–1PubMed
26.
Gilbeau L, Kantor G, Stoeckle E, et al. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol 2002; 65(3):137–43PubMedCrossRef
27.
Mendenhall WM, Zlotecki RA, Hochwald SN, et al. Retroperitoneal soft tissue sarcoma. Cancer 2005; 104(4):669–75PubMedCrossRef
Metadata
Title
Retroperitoneal and Truncal Sarcomas: Prognosis Depends Upon Type Not Location
Authors
Eduardo A. Perez, MD
Juan C. Gutierrez, MD
Frederick L. Moffat Jr, MD
Dido Franceschi, MD
Alan S. Livingstone, MD
Seth A. Spector, MD
Joe U. Levi, MD
Danny Sleeman, MD
Leonidas G. Koniaris, MD
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 3/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9255-x

Other articles of this Issue 3/2007

Annals of Surgical Oncology 3/2007 Go to the issue

OriginalPaper

Timing of Resection of Liver Metastases Synchronous to Colorectal Tumor: Proposal of Prognosis-Based Decisional Model

OriginalPaper

The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer

OriginalPaper

Comparison Between Local Ablative Therapy and Chemotherapy for Non-Resectable Colorectal Liver Metastases: A Prospective Study

OriginalPaper

Laparoscopic Distal Pancreatectomy in Children: Case Report and Review of the Literature

OriginalPaper

Kinase Mutations and Imatinib Mesylate Response for 64 Taiwanese with Advanced GIST: Preliminary Experience from Chang Gung Memorial Hospital

EditorialNotes

Monitoring Health Outcomes Following Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis